These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19043266)

  • 1. Alendronate-induced esophagitis: possible pathogenic role of hypersensitivity to alendronate.
    Naniwa T; Maeda T; Mizoshita T; Hayami Y; Watanabe M; Banno S; Ito R
    Intern Med; 2008; 47(23):2083-5. PubMed ID: 19043266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ulcerative esophagitis associated with the use of alendronate sodium: histopathological and endoscopic features].
    Fernandes PA; Pires MS; Gouvêa AP
    Arq Gastroenterol; 2002; 39(3):173-6. PubMed ID: 12778309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alendronate-induced esophagitis: case report of a recently recognized form of severe esophagitis with esophageal stricture--radiographic features.
    Ryan JM; Kelsey P; Ryan BM; Mueller PR
    Radiology; 1998 Feb; 206(2):389-91. PubMed ID: 9457190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alendronate-induced severe esophagitis. A rare and severe reversible side-effect illustrated by three case reports].
    Tóth E; Fork FT; Lindelöw K; Lindström E; Verbaan H; Veress B
    Lakartidningen; 1998 Aug; 95(35):3676-80. PubMed ID: 9748782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esophagitis associated with the use of alendronate.
    de Groen PC; Lubbe DF; Hirsch LJ; Daifotis A; Stephenson W; Freedholm D; Pryor-Tillotson S; Seleznick MJ; Pinkas H; Wang KK
    N Engl J Med; 1996 Oct; 335(14):1016-21. PubMed ID: 8793925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Esophagitis associated with use of alendronate in 5 postmenopausic patients].
    Luciani J; Pigatto V; Naves A; Fay M; Silvestre Begnis M; Piola JC; Prada DB; Pedrana R
    Acta Gastroenterol Latinoam; 2001 May; 31(2):59-63. PubMed ID: 11471319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alendronate-associated esophageal injury: pathologic and endoscopic features.
    Abraham SC; Cruz-Correa M; Lee LA; Yardley JH; Wu TT
    Mod Pathol; 1999 Dec; 12(12):1152-7. PubMed ID: 10619269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Esophagitis associated with alendronate sodium.
    Pizzani E; Valenzuela G
    Va Med Q; 1997; 124(3):181-2. PubMed ID: 9227047
    [No Abstract]   [Full Text] [Related]  

  • 9. [Alendronate-induced esophagitis. A report of 2 cases].
    Girelli CM; Reguzzoni G; Rocca F
    Recenti Prog Med; 1997 May; 88(5):223-5. PubMed ID: 9244956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Images of interest. Gastrointestinal: esophagitis caused by alendronate.
    Sia KK; Iser D; Heng R; Chen RY
    J Gastroenterol Hepatol; 2004 Aug; 19(8):936. PubMed ID: 15242500
    [No Abstract]   [Full Text] [Related]  

  • 11. Avoiding alendronate-related esophageal irritation.
    Lilley LL; Guanci R
    Am J Nurs; 1997 Jul; 97(7):12-4. PubMed ID: 9247373
    [No Abstract]   [Full Text] [Related]  

  • 12. [Esophagitis associated with the use of alendronate].
    Larzillière I; Gargot D; Zleik T; Ramain JP
    Gastroenterol Clin Biol; 1999 Oct; 23(10):1098-9. PubMed ID: 10592886
    [No Abstract]   [Full Text] [Related]  

  • 13. Pill esophagitis.
    Vãlean S; Petrescu M; Cãtinean A; Chira R; Mircea PA
    Rom J Gastroenterol; 2005 Jun; 14(2):159-63. PubMed ID: 15990936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alendronate-induced esophagitis.
    CMAJ; 1998 Apr; 158(7):941-2, 945-6. PubMed ID: 9559022
    [No Abstract]   [Full Text] [Related]  

  • 15. Esophagitis dissecans superficialis and alendronate: case report.
    Cameron RB
    Gastrointest Endosc; 1997 Dec; 46(6):562-3. PubMed ID: 9434230
    [No Abstract]   [Full Text] [Related]  

  • 16. Esophageal irritation due to alendronate sodium tablets: possible mechanisms.
    Peter CP; Handt LK; Smith SM
    Dig Dis Sci; 1998 Sep; 43(9):1998-2002. PubMed ID: 9753265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-induced esophagitis.
    Zografos GN; Georgiadou D; Thomas D; Kaltsas G; Digalakis M
    Dis Esophagus; 2009; 22(8):633-7. PubMed ID: 19392845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. United Kingdom experience with alendronate and oesophageal reactions.
    Mackay FJ; Wilton LV; Pearce GL; Freemantle SN; Mann RD
    Br J Gen Pract; 1998 Apr; 48(429):1161-2. PubMed ID: 9667093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical tolerability profile of alendronate.
    Watts N; Freedholm D; Daifotis A
    Int J Clin Pract Suppl; 1999 Apr; 101():51-61. PubMed ID: 12669741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eosinophilic esophagitis is a component of the anticonvulsant hypersensitivity syndrome: description of two cases.
    Balatsinou C; Milano A; Caldarella MP; Laterza F; Pierdomenico SD; Cuccurullo F; Neri M
    Dig Liver Dis; 2008 Feb; 40(2):145-8. PubMed ID: 17395557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.